SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Rezolute, Inc. (RZLT) (CIK 0001509261) (RZLT) — Apr 8, 2014

Rezolute, Inc. (RZLT) (CIK 0001509261)
Date: April 8, 2014 · CIK: 0001509261 · Accession: 0000000000-14-017556

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 000-54495

Date
April 8, 2014
Author
/s/ Daniel Greenspan for
Form
UPLOAD
Company
Rezolute, Inc. (RZLT) (CIK 0001509261)

Letter

April 8, 2014 Via E -mail Nevan Elam Chief Executive Officer AntriaBio, Inc. 890 Santa Cruz Avenue Menlo Park , CA 94025

Re: AntriaBio, Inc. Preliminary Proxy Statement on Schedule 14C Filed March 31 , 2014 File No. 000-54495

Dear Mr. Elam :

We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Daniel Greenspan for

Show Raw Text
April 8, 2014

Via E -mail
Nevan Elam
Chief Executive Officer
AntriaBio, Inc.
890 Santa Cruz Avenue
Menlo Park , CA 94025

Re: AntriaBio, Inc.
Preliminary  Proxy Statement on Schedule 14C
Filed March 31 , 2014
File No. 000-54495

Dear Mr. Elam :

We have completed our review of your filing .  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

 /s/ Daniel  Greenspan for

 Jeffrey P. Riedler
Assistant Director

cc:  Via E -mail
Anthony W. Epps
Dorsey & Whitney LLP
1400 Wewatta Street
Suite 400
Denver, CO 80202 -5549